Revelation Biosciences Inc (REVB)

$1.83

-0.08

(-4.19%)

Market is closed - opens 7 PM, 28 May 2024

Performance

  • $1.79
    $1.91
    $1.83
    downward going graph

    2.19%

    Downside

    Day's Volatility :6.28%

    Upside

    4.18%

    downward going graph
  • $1.78
    $35.40
    $1.83
    downward going graph

    2.73%

    Downside

    52 Weeks Volatility :94.97%

    Upside

    94.83%

    downward going graph

Returns

PeriodRevelation Biosciences Inc
3 Months
-42.09%
6 Months
-90.69%
1 Year
-94.55%
3 Years
-99.98%

Highlights

Market Capitalization
3.3M
Book Value
$25.13
Earnings Per Share (EPS)
-0.53
Wall Street Target Price
18.7
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-61.08%
Return On Equity TTM
-3.12%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
90.9M
EBITDA
-8.6M
Diluted Eps TTM
-0.53
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-7.53
EPS Estimate Next Year
-5.23
EPS Estimate Current Quarter
-5.38
EPS Estimate Next Quarter
-5.18

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Revelation Biosciences Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 921.86%

Current $1.83
Target $18.70

Technicals Summary

Sell

Neutral

Buy

Revelation Biosciences Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Revelation Biosciences Inc
Revelation Biosciences Inc
-14.48%
-90.69%
-94.55%
-99.98%
-99.98%
Moderna, Inc.
Moderna, Inc.
56.91%
114.37%
31.74%
-1.57%
673.49%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
10.59%
23.42%
35.86%
97.78%
219.88%
Novo Nordisk A/s
Novo Nordisk A/s
8.15%
30.97%
67.5%
238.49%
467.54%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
14.9%
30.49%
37.37%
118.89%
164.5%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Revelation Biosciences Inc
Revelation Biosciences Inc
0.5
NA
NA
-7.53
-0.03
-0.61
NA
25.13
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-6.6
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
28.99
28.99
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
46.75
46.75
2.36
3.5
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
29.23
29.23
0.53
17.14
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Revelation Biosciences Inc
Revelation Biosciences Inc
Buy
$3.3M
-99.98%
0.5
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$63.9B
673.49%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$108.0B
219.88%
28.99
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$605.7B
467.54%
46.75
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$116.3B
164.5%
29.23
39.46%

Institutional Holdings

    Company Information

    we develop immunologic therapeutics and diagnostics designed to make the world a healthier place

    Organization
    Revelation Biosciences Inc
    Employees
    9
    CEO
    Mr. James M. Rolke
    Industry
    Regional Banks

    FAQs